Respiratory Syncytial Virus-associated hospitalization in premature infants who did not receive palivizumab prophylaxis in Italy: a retrospective analysis from the Osservatorio Study

BACKGROUND: Due to different social and epidemiological factors, the eligibility criteria to receive palivizumab prophylaxis may be different between countries, especially in “otherwise healthy” late preterm infants. METHODS: We analyzed an Italian database of young children referred to emergency de...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Ital J Pediatr
Egile Nagusiak: Silvestri, Michela, Marando, Francesca, Costanzo, Anna Maria, di Luzio Paparatti, Umberto, Rossi, Giovanni A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2016
Gaiak:
Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4845497/
https://ncbi.nlm.nih.gov/pubmed/27112952
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13052-016-0252-9
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak